Randomized phase II study of consolidation immunotherapy with nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small-cell lung cancer (NSCLC): Big Ten Cancer Research Consortium LUN16-081.

Saved in:
Bibliographic Details
Title: Randomized phase II study of consolidation immunotherapy with nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small-cell lung cancer (NSCLC): Big Ten Cancer Research Consortium LUN16-081.
Authors: Durm G; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA gdurm@iu.edu., Mamdani H; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, USA., Althouse S; Indiana University Richard M Fairbanks Department of Biostatistics, Indianapolis, Indiana, USA., Perkins S; Indiana University Richard M Fairbanks Department of Biostatistics, Indianapolis, Indiana, USA., Jabbour SK; Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Ganti AK; Oncology-Hematology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; VA Nebraska-Western Iowa Health Care System, Grand Island, Nebraska, USA., Jalal S; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.; Richard L Roudebush VA Medical Center, Indianapolis, Indiana, USA., Chesney J; University of Louisville School of Medicine, Louisville, Kentucky, USA., Naidoo J; Beaumont Hospital, Dublin, Ireland.; RCSI University of Health Sciences, Dublin, Ireland.; Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA., Hrinczenko B; Michigan State University College of Human Medicine, East Lansing, Michigan, USA., Fidler MJ; Rush University Medical Center, Chicago, Illinois, USA., Leal TA; Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA., Feldman L; University of Illinois Cancer Center, Chicago, Illinois, USA.; Jesse Brown VA Medical Center, Chicago, Illinois, USA., Fujioka N; University of Minnesota, Minneapolis, Minnesota, USA., Hanna NH; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Jul 15; Vol. 13 (7). Date of Electronic Publication: 2025 Jul 15.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2024-010316